from Reuters: Health News https://ift.tt/2GPg6dF
Novartis faces shareholder criticism over drug prices at AGM
Novartis's shift into high-tech drugs won praise for providing patients with new options but criticism over prices that may run into the millions of dollars at the Swiss drugmaker's annual general meeting on Thursday.
from Reuters: Health News https://ift.tt/2GPg6dF
from Reuters: Health News https://ift.tt/2GPg6dF
Subscribe to:
Post Comments (Atom)
-
The German cabinet will hold a secret session on Wednesday to discuss safeguard measures regarding the possible participation of China's...
-
Stocks poised for another day of gains Equity markets look to add to the gains from the prior session as investor concerns about the fu...
-
By LIAM STACK from NYT Magazine https://ift.tt/2FNPp6k
No comments:
Post a Comment